8E6-14395-61579
2 vaccinations
1 coded response
15 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 12-15
- ZIP prefix
- 667 / KS
- Registered
- 2022-02-02
- Relationship
- Child or adolescent in my care
- Guardian
- 3M8-23018-92658
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-21
Dose 1 — Pfizer-BioNTech
-
2022-02-02
Registered in v-safe
- 2022-02-02
- 2022-02-04
-
2022-02-11
Dose 2 — Pfizer-BioNTech
- 2022-02-13
- 2022-02-14
- 2022-02-15
-
2022-02-17
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Fever · Be unable to work or attend schoolFree text: Sore throat, congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-02-18
- 2022-02-25
- 2022-03-04
- 2022-03-11
- 2022-03-18
- 2022-03-25
- 2022-05-13
- 2022-08-12
- 2023-02-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-21 | Pfizer-BioNTech | No |
| 2 | 2022-02-11 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Sore throat, congestion, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release